Vicks Inhaler 1.0 g Inhaler
PDF Leaflet Revision Date: 18 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of nasal congestion associated with upper respiratory tract disorders.
Dosage (summary)
Adults and children over 6 years: use as needed; not for children under 6.
Pregnancy & Breastfeeding
No evidence against use during pregnancy and lactation.
Contraindications
- Hypersensitivity to menthol or camphor
- Asthma and respiratory hypersensitivities
Common side effects
- Hypersensitivity reactions
- Nasal discomfort
Counselling Points
- Use only as intended
- For external use only
Serious warnings
- Consult doctor if no improvement after 7 days
- Avoid contact with eyes
Important Disclaimer
The Vicks Inhaler 1.0 g Inhaler professional information leaflet below is the property of P&G South African Trading and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
Clinical Particulars
Section 4 of the official insert — extracted exactly as issued, no alterations
4.1 Therapeutic indications
The relief of nasal congestion associated with allergic and infectious upper respiratory tract disorders.
4.2 Posology and method of administration
Posology
Adults and children over 6 years: It can be used as frequently as needed.
Paediatric population
Do not used in children under 6 years.
Method of administration
Vicks inhaler is used by inserting the inhaler into one nostril, while holding the other nostril closed and inhaling deeply. Use only as intended. For external use only (see section 6.6). If no significant improvement in symptoms has occurred after 7 days, the patient is advised to consult a doctor because a more serious illness may be present.
4.3 Contraindications
Hypersensitivity to menthol, camphor or to any of the excipients listed in section 6.1. Asthma and other respiratory hypersensitivities.
4.4 Special warnings and precautions for use
If there is no improvement or if there is aggravation of the disorder consult your doctor. Avoid contact with the eyes.
4.5 Interaction with other medicines and other forms of interaction
None.
4.6 Fertility, pregnancy and lactation
There is no evidence to indicate that this product should not be used during pregnancy and lactation.
4.7 Effects on ability to drive and use machines
None.
4.8 Undesirable effects
In general, no serious or severe side effects are expected with this product. Consult a doctor if symptoms persist.
Medra System Organ Class
Frequency
Side Effects
Immune system disorders
Very rare
Hypersensitivity reactions including contact dermatitis
Respiratory, thoracic and mediastinal disorders
Very rare
Nasal discomfort (e.g. temporary burning, stinging, sneezing, or increased nasal discharge)
4.9 Overdose
No clinically significant cases of overdose have been reported. Treatment is symptomatic and supportive.
